Correlation Between NYSE Composite and Vor Biopharma
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Vor Biopharma, you can compare the effects of market volatilities on NYSE Composite and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Vor Biopharma.
Diversification Opportunities for NYSE Composite and Vor Biopharma
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Vor is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of NYSE Composite i.e., NYSE Composite and Vor Biopharma go up and down completely randomly.
Pair Corralation between NYSE Composite and Vor Biopharma
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.13 times more return on investment than Vor Biopharma. However, NYSE Composite is 7.84 times less risky than Vor Biopharma. It trades about 0.11 of its potential returns per unit of risk. Vor Biopharma is currently generating about -0.07 per unit of risk. If you would invest 1,550,264 in NYSE Composite on August 31, 2024 and sell it today you would earn a total of 476,940 from holding NYSE Composite or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Vor Biopharma
Performance |
| Timeline |
NYSE Composite and Vor Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Vor Biopharma
Pair trading matchups for Vor Biopharma
Pair Trading with NYSE Composite and Vor Biopharma
The main advantage of trading using opposite NYSE Composite and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| Vor Biopharma vs. Cue Biopharma | Vor Biopharma vs. Eliem Therapeutics | Vor Biopharma vs. Inhibrx | Vor Biopharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets |